Chemicals and reagents
A 15 mixed standards of PAHs including; benzo[c]fluorene (B[c]F,97%), benzo[a]anthracene (B[a]A,99%), chrysene (CHR, 99%), 5-metylchrysene (5-MChr,99%), cyclopenta[c,d]pyrene (C[cd]P,99%), benzo[b]fluoranthene (B[b]F,99%), benzo[k]fluoranthene (B[k]F,99%), benzo[a]pyrene (B[a]P,99%), dibenzo[a,h]anthracene (D[ah]A, 99%), indeno[1,2,3-cd]pyrene (I[cd]P, 99%), benzo[g,h,i]perylene (B[ghi]P, 99%), dibenzo[a,l]pyrene (D[al]P, 99%), dibenzo[a,e]pyrene (D[ae]P, 99%), dibenzo[a,i]pyrene (D[ai]P, 99%) and dibenzo[a,h]pyrene (D[ah]P, 99%) were provided from Restek company (United States) and 9 single chemicals including; Phenanthrene (PHE, 99.20%), Naphthalene (NPH, 99.40%), Fluorene (FLR, 99.90%), Fluoranthene (FLA, 98.7%), Pyrene (PYR, 98%), Anthracene (ANT, 99.40%), Acenaphthene (ACP, 99.9%), Perylene (PER, 99.9%), Acenaphtylene (ACL, 99.9%) were prepared from Sigma Aldrich (United states). Stock standards of 9 single PAHs were prepared at concentration 1000.0 μg/mL in Ethyl acetate then; a mixed solution of all PAHs standards was made ready by dissolving appropriate concentration of 15 mixed standards and 9 single standards in acetonitrile at a concentration of 5.0 μg/mL. Primary and working standards were prepared from the final mixed standard. All standard solutions were stored in amber flasks at -20 °C.
Triphenylphosphate (TPP), as internal standard was obtained from Sigma–Aldrich (Germany). A stock solution of TPP in ethyl acetate at concentration of 10.0 μg/mL was prepared and a 50.0 μL of its solutions was added to the spiked bread samples. Anhydrous magnesium sulfate (MgSO4) was acquired from Sigma–Aldrich (Germany) and Methanol (MeOH) and HPLC-grade acetonitrile (MeCN) from Acros (Belgium). Ethyl acetate (EtAc) and sodium acetate were supplied from Merck (Darmstadt, Germany). Bondesil-primary secondary amine (PSA, 40 μm) was provided from Interchim (France). A Milli-Q Plus ultra-pure water system (Molsheim, France) was applied for preparation of HPLC grade water.
Instrument Analysis
All samples were determined using an Agilent 7890A GC instrument coupled a 5975C mass detector with split/spiltless injector, and 7693 autosampler (Agilent technologies, USA). A DB-5MS 122-5532UI capillary column (30 m × 0.25 mm I.D., 0.25-μm film) from Agilent technologies and Helium carrier gas (purity 99.999%) at a constant flow rate of 1.6 mL/min with the following oven temperature program was applied: 80 °C (2 min), 20 °C/min ramp to 140 °C (1 min), then 5 °C/min ramp to 315 °C. Injection port, quadrupole mass analyser, transfer line and ion source was adjusted at 300 °C, 100 °C, 280 °C, and 230 °C, respectively and splitless mode was used. A mass range of m/z 50-500 was scanned to find the retention time and diagnostic ions (quantification and confirmation ions) of the analytes. After acquisition of the diagnostic ions in selected ion monitoring (SIM) mode, the retention times and mass spectra of selected ions were used to identification of peaks. At least three ions were used to recognition and determination of analytes. The most abundant ions with the highest signal-to-noise ratios were chosen as quantifiers and the others were qualifiers. All identified peaks were confirmed by comparing the relative abundances of studied ions of PAHs to the related spectra in the mass reference library.
Sample preparation
Sample preparation including, extraction and clean-up was performed according to the QuEChERS method (
24). The bread samples were carefully ground and homogenized, then a 5 g portion of the obtained powder was transferred into a 50 mL falcon tube. The desired amounts of the mixed PAH standard (for spiking) and 50 µL TPP (200 ng/mL) were included to the tube. Thereafter, by adding 14 mL of MeCN, the studied PAHs were taken out bread. The tube content was vortex mixed for 3.0 min, then 2 g anhydrous MgSO
4 and 1.5 g sodium acetate were added and after mixing for another 3.0 min the content was introduced to a centrifuge 9055×g for 20 min. After centrifugation, the 7 mL of supernatant was taken into a suitable tube and evaporated until dryness by a nitrogen evaporator. The remainder was reconstituted in 0.5 mL MeCN and sonicated 10.0 min then vortex mixed for 3.0 min. The obtained solution was transferred to a micro tube containing 60 mg anhydrous MgSO4 and 20 mg PSA and vortex mixed vigorously for 1min and centrifuged for 5 min 18894×g. Finally, a desired amount of aliquot was transferred into a screw cap vial and 2.0 μL was injected into GC-MS.
Method validation
For validation studies, various parameters including; linearity, recovery, precision, limits of detection (LOD) and limits of quantification (LOQ) were calculated (
25-
27). Linearity was assessed applying spiked calibrations by analyzing in triplicate six concentration levels, between 10 and 500 ng/g. To estimation of the accuracy (recovery studies) and the precision, three spiked blank bread samples at concentration levels of 25, 50, and 200 ng/g were prepared. The matrix effects were calculated as: [1 - (spiked calibration curve slope/solvent base calibration curve slope)] ×100 (
24). LODs and LOQs were estimated according to the concentrations of PAH resulting in a signal-to-noise ratio of 3 and 10, respectively. The amounts of PAHs in Taftoon samples were calculated by interpolation of the peak areas for each PAH to internal standard peak area in the sample.
Determination of PAHs in Taftoon samples
Seventy-two traditional and thirty-three semi- industrial Taftoon bread samples collected from Taftoon bakeries located in Tehran city. Traditional bread were baked by direct heating in the temperature range of 216-300 °C and semi-industrial bread were baked by indirect heating at temperatures between 160 and 300 °C in different distance of heating source. Natural gas had been used for both of the oven. After collection, all of the samples were covered with aluminum foil and transported to the lab. Each sample was coded and dried to lose its moisture within one day. Then all of the samples were ground and stored in amber glass bottles at −20 °C until analysis. Finally, 50 g portion of homogenized samples was weighted and analyzed.
| NO. | Compounds | MolecularWeights (g/mol) | Quantification Ions (m/z) | Confirmation Ions (m/z) | Ion Ratios | Retention Times (min) |
|---|
| 1 | NPH | 128 | 128 | 128 ,129*,64 | 8.393 | 5.19 |
| 2 | ACL | 152 | 152 | 152,151*,76 | 4.509 | 8.18 |
| 3 | ACP | 154 | 153 | 153,154*,76 | 3.231 | 8.63 |
| 4 | FLR | 166 | 166 | 166,165*,82 | 1.176 | 10.16 |
| 5 | PHE | 178 | 178 | 178,176*,152 | 5.13 | 12.91 |
| 6 | ANT | 178 | 178 | 178,176*,152 | 8.441 | 13.09 |
| 7 | FLA | 202 | 202 | 202, 203*,201 | 6.76 | 17.40 |
| 8 | PYR | 202 | 202 | 202, 203*,201 | 6.546 | 18.27 |
| 9 | B(c)F | 216 | 216 | 216, 215*,217 | 1.349 | 20.17 |
| 10 | CP(c,d)P | 226 | 226 | 226, 227*,225 | 8.634 | 23.49 |
| 11 | B(a)A | 228 | 228 | 228.226*,229 | 2.906 | 23.66 |
| 12 | CHR | 228 | 228 | 228.226*,229 | 3.456 | 23.79 |
| 13 | 5-M-CHR | 242 | 242 | 242, 241*,239 | 2.158 | 25.82 |
| 14 | B(b)F | 252 | 252 | 252, 253*,250 | 5.106 | 28.25 |
| 15 | B(k)F | 252 | 252 | 252, 253*,250 | 3.431 | 28.35 |
| 16 | B(a)P | 252 | 252 | 252, 253*,250 | 6.624 | 29.76 |
| 17 | PER | 252 | 252 | 252, 253*,250 | 4.613 | 29.96 |
| 18 | I(1,2,3-cd)P | 276 | 276 | 276, 277*,138 | 5.071 | 33.45 |
| 19 | DB(a,h)A | 278 | 278 | 278, 276*,138 | 3.733 | 33.67 |
| 20 | B(g,h,i)PER | 276 | 276 | 276, 138*,277 | 20.08 | 34.25 |
| 21 | DB(a,l)P | 302 | 302 | 302, 303*,300 | 4.329 | 37.84 |
| 22 | DB(a,e)P | 302 | 302 | 302, 303*,300 | 4.784 | 38.84 |
| 23 | DB(a,i)P | 302 | 302 | 302, 303*,300 | 4.395 | 39.19 |
| 24 | DB(a,h)P | 302 | 302 | 302, 303*,300 | 3.151 | 39.37 |
| NO. | Compound | Spiked calibration curve of bread
| Solvent calibrationcurve
| A | Matrix Effect (%) |
|---|
| Slope | R2 | Slope | R2 |
|---|
| 1 | NPH | 0.0002 | 0.989 | 0.009 | 0.998 | 0.022 | 97.78 |
| 2 | ACL | 0.002 | 0.998 | 0.023 | 0.997 | 0.098 | 90.15 |
| 3 | ACP | 0.002 | 0.998 | 0.026 | 0.991 | 0.088 | 91.19 |
| 4 | FLR | 0.005 | 0.997 | 0.020 | 0.999 | 0.249 | 75.12 |
| 5 | PHE | 0.005 | 0.998 | 0.010 | 0.994 | 0.490 | 50.94 |
| 6 | ANT | 0.003 | 0.998 | 0.008 | 0.999 | 0.410 | 58.98 |
| 7 | FLA | 0.007 | 0.999 | 0.018 | 0.994 | 0.379 | 62.13 |
| 8 | PYR | 0.007 | 0.996 | 0.041 | 0.992 | 0.175 | 82.47 |
| 9 | B(c)F | 0.006 | 0.999 | 0.059 | 0.999 | 0.103 | 89.72 |
| 10 | CP(c,d)P | 0.006 | 0.996 | 0.015 | 0.993 | 0.375 | 62.48 |
| 11 | B(a)A | 0.005 | 0.999 | 0.004 | 0.999 | 1.366 | -36.64 |
| 12 | CHR | 0.006 | 0.999 | 0.013 | 0.998 | 0.423 | 57.65 |
| 13 | 5-M-CHR | 0.005 | 0.999 | 0.014 | 0.995 | 0.352 | 64.80 |
| 14 | B(b)F | 0.008 | 0.999 | 0.012 | 0.999 | 0.705 | 29.52 |
| 15 | B(k)F | 0.003 | 0.999 | 0.009 | 0.999 | 0.341 | 65.91 |
| 16 | B(a)P | 0.006 | 0.992 | 0.016 | 0.995 | 0.393 | 60.71 |
| 17 | PER | 0.007 | 0.999 | 0.026 | 0.997 | 0.265 | 73.48 |
| 18 | I(1,2,3-cd)P | 0.006 | 0.998 | 0.014 | 0.993 | 0.422 | 57.79 |
| 19 | DB(a,h)A | 0.005 | 0.999 | 0.002 | 0.990 | 2.174 | -117.38 |
| 20 | B(g,h,i)PER | 0.009 | 0.998 | 0.015 | 0.999 | 0.616 | 38.44 |
| 21 | DB(a,l)P | 0.004 | 0.998 | 0.014 | 0.997 | 0.271 | 72.93 |
| 22 | DB(a,e)P | 0.004 | 0.999 | 0.025 | 0.994 | 0.157 | 84.27 |
| 23 | DB(a,i)P | 0.003 | 0.996 | 0.025 | 0.994 | 0.127 | 87.33 |
| 24 | DB(a,h)P | 0.002 | 0.998 | 0.026 | 0.994 | 0.078 | 92.15 |
| NO. | Compound | Regression Equation (n = 18) | Coefficients of Determination (R2) | LODa | LOQb |
|---|
| 1 | NPH | y = 0.0003x + 0.009 | 0.99 | 1.49 | 4.91 |
| 2 | ACL | y = 0.002x + 0.038 | 0.998 | 0.65 | 2.50 |
| 3 | ACP | y = 0.025x + 0.134 | 0.991 | 0.65 | 2.15 |
| 4 | FLR | y = 0.005x + 0.052 | 0.997 | 0.75 | 2.48 |
| 5 | PHE | y = 0.005x + 0.077 | 0.998 | 0.61 | 2.01 |
| 6 | ANT | y = 0.003x + 0.011 | 0.998 | 0.56 | 1.85 |
| 7 | FLA | y = 0.006x - 0.006 | 0.999 | 0.14 | 0.46 |
| 8 | PYR | y = 0.007x - 0.037 | 0.996 | 0.87 | 2.88 |
| 9 | B(c)F | y = 0.006x - 0.002 | 0.999 | 0.18 | 0.60 |
| 10 | CP(c,d)P | y = 0.005x - 0.002 | 0.996 | 0.82 | 2.71 |
| 11 | B(a)A | y = 0.005x + 0.012 | 0.999 | 0.24 | 0.80 |
| 12 | CHR | y = 0.013x - 0.068 | 0.998 | 0.20 | 0.67 |
| 13 | 5-M-CHR | y = 0.005x + 7E-05 | 0.999 | 0.24 | 0.80 |
| 14 | B(b)F | y = 0.008x + 0.015 | 0.999 | 0.35 | 1.15 |
| 15 | B(k)F | y = 0.003x + 0.008 | 0.999 | 0.39 | 1.28 |
| 16 | B(a)P | y = 0.017x - 0.106 | 0.994 | 0.79 | 2.59 |
| 17 | PER | y = 0.006x + 0.012 | 0.999 | 0.39 | 1.29 |
| 18 | I(1,2,3-cd)P | y = 0.006x + 0.021 | 0.998 | 0.56 | 1.85 |
| 19 | DB(a,h)A | y = 0.005x + 0.004 | 0.999 | 0.36 | 1.19 |
| 20 | B(g,h,i)PER | y = 0.009x + 0.072 | 0.998 | 0.58 | 1.90 |
| 21 | DB(a,l)P | y = 0.014x - 0.057 | 0.997 | 0.59 | 1.96 |
| 22 | DB(a,e)P | y = 0.004x + 0.011 | 0.999 | 0.30 | 1.52 |
| 23 | DB(a,i)P | y = 0.003x + 0.020 | 0.996 | 0.84 | 2.76 |
| 24 | DB(a,h)P | y = 0.002x + 0.027 | 0.998 | 0.57 | 1.88 |
| NO. | Compound | 25 (ng/g)
| 50 (ng/g)
| 200 (ng/g)
| Average recovery(n = 27) | AverageRSD(n = 27) |
|---|
| Recovery | RSD | Recovery | RSD | Recovery | RSD |
|---|
| 1 | NPH | 117.72 | 17.28 | 111.36 | 10.83 | 71.14 | 18.69 | 100.07 | 15.60 |
| 2 | ACL | 98.21 | 4.77 | 111.72 | 6.89 | 99.18 | 10.81 | 103.04 | 7.49 |
| 3 | ACP | 114.96 | 6.58 | 108.04 | 9.59 | 75.99 | 18.35 | 99.66 | 11.51 |
| 4 | FLR | 90.37 | 3.36 | 92.15 | 6.14 | 104.91 | 5.36 | 103.04 | 7.49 |
| 5 | PHE | 89.19 | 1.39 | 96.83 | 6.04 | 79.89 | 15.22 | 88.64 | 7.55 |
| 6 | ANT | 93.96 | 1.37 | 98.26 | 5.09 | 80.65 | 13.47 | 90.96 | 6.64 |
| 7 | FLA | 108.52 | 1.11 | 107.89 | 2.31 | 77.28 | 10.25 | 97.89 | 4.56 |
| 8 | PYR | 115.40 | 0.94 | 112.79 | 1.66 | 78.38 | 7.97 | 102.19 | 3.52 |
| 9 | B(c)F | 104.73 | 1.09 | 105.96 | 1.76 | 74.29 | 9.33 | 94.99 | 4.06 |
| 10 | CP(c,d)P | 92.13 | 1.76 | 85.25 | 2.16 | 64.17 | 7.38 | 80.52 | 3.77 |
| 11 | B(a)A | 86.75 | 3.58 | 94.43 | 2.01 | 81.26 | 20.11 | 87.48 | 8.57 |
| 12 | CHR | 100.15 | 1.67 | 99.95 | 1.89 | 72.09 | 10.20 | 90.73 | 4.59 |
| 13 | 5-M-CHR | 100.69 | 1.62 | 103.70 | 1.96 | 73.47 | 10.67 | 92.62 | 4.75 |
| 14 | B(b)F | 93.35 | 1.93 | 104.36 | 2.74 | 73.24 | 9.18 | 90.31 | 4.62 |
| 15 | B(k)F | 90.31 | 2.44 | 98.06 | 2.56 | 74.08 | 13.40 | 87.49 | 6.13 |
| 16 | B(a)P | 90.28 | 3.09 | 94.18 | 4.40 | 67.10 | 8.70 | 83.85 | 5.40 |
| 17 | PER | 96.94 | 1.99 | 103.72 | 2.27 | 76.38 | 7.76 | 92.35 | 4.01 |
| 18 | I(1,2,3-cd)P | 82.10 | 1.63 | 88.71 | 5.90 | 61.90 | 14.53 | 77.57 | 7.35 |
| 19 | DB(a,h)A | 116.87 | 4.42 | 108.82 | 5.16 | 80.93 | 13.58 | 102.20 | 7.72 |
| 20 | B(g,h,i)PER | 91.46 | 1.71 | 101.39 | 3.92 | 69.57 | 7.33 | 87.48 | 4.32 |
| 21 | DB(a,l)P | 81.52 | 2.89 | 100.76 | 4.83 | 71.23 | 6.67 | 84.51 | 4.80 |
| 22 | DB(a,e)P | 101.24 | 4.07 | 116.09 | 4.32 | 73.38 | 8.36 | 96.90 | 5.58 |
| 23 | DB(a,i)P | 75.87 | 2.95 | 94.87 | 5.91 | 64.38 | 14.12 | 78.38 | 7.66 |
| 24 | DB(a,h)P | 101.42 | 6.42 | 108.69 | 7.43 | 75.86 | 37.94 | 95.33 | 17.26 |
| NO. | Compound | Numbers of positive samples | LOD(ng/g) | LOQ(ng/g) | Mean(ng/g) | Min Level(ng/g) | Max Level(ng/g) |
|---|
| 1 | NPH | 20 (27.8%) | 1.49 | 4.91 | 88.68 | 7.17 | 201.10 |
| 2 | ACL | 0 | 0.65 | 2.50 | 0 | nd | nd |
| 3 | ACP | 0 | 0.65 | 2.15 | 0 | nd | nd |
| 4 | FLR | 0 | 0.75 | 2.48 | 0 | nd | nd |
| 5 | PHE | 1 (1.4%) | 0.61 | 2.01 | 2.29 | - | 2.29 |
| 6 | ANT | 5 (6.9%) | 0.56 | 1.85 | 12.33 | 9.82 | 18.09 |
| 7 | FLA | 0 | 0.14 | 0.46 | 0 | nd | nd |
| 8 | PYR | 0 | 0.87 | 2.88 | 0 | nd | nd |
| 9 | B(c)F | 0 | 0.18 | 0.60 | 0 | nd | nd |
| 10 | CP(c,d)P | 0 | 0.82 | 2.71 | 0 | nd | nd |
| 11 | B(a)A | 0 | 0.24 | 0.80 | 0 | nd | nd |
| 12 | CHR | 0 | 0.20 | 0.67 | 0 | nd | nd |
| 13 | 5-M-CHR | 0 | 0.24 | 0.80 | 0 | nd | nd |
| 14 | B(b)F | 0 | 0.35 | 1.15 | 0 | nd | nd |
| 15 | B(k)F | 0 | 0.39 | 1.28 | 0 | nd | nd |
| 16 | B(a)P | 0 | 0.79 | 2.59 | 0 | nd | nd |
| 17 | PER | 0 | 0.39 | 1.29 | 0 | nd | nd |
| 18 | I(1,2,3-cd)P | 0 | 0.56 | 1.85 | 0 | nd | nd |
| 19 | DB(a,h)A | 0 | 0.36 | 1.19 | 0 | nd | nd |
| 20 | B(g,h,i)PER | 0 | 0.58 | 1.90 | 0 | nd | nd |
| 21 | DB(a,l)P | 0 | 0.59 | 1.96 | 0 | nd | nd |
| 22 | DB(a,e)P | 0 | 0.30 | 1.52 | 0 | nd | nd |
| 23 | DB(a,i)P | 0 | 0.84 | 2.76 | 0 | nd | nd |
| 24 | DB(a,h)P | 0 | 0.57 | 1.88 | 0 | nd | nd |
| ∑24 PAHs | 26 (36.1%) | - | - | 70.67 | 2.29 | 201.10 |
| NO. | Compound | Numbers of positive samples | LOD(ng/g) | LOQ(ng/g) | Mean(ng/g) | Min Level(ng/g) | Max Level(ng/g) |
|---|
| 1 | NPH | 7 (21.2%) | 1.49 | 4.91 | 46.39 | 5.09 | 241.15 |
| 2 | ACL | 0 | 0.65 | 2.50 | 0 | nd | nd |
| 3 | ACP | 0 | 0.65 | 2.15 | 0 | nd | nd |
| 4 | FLR | 0 | 0.75 | 2.48 | 0 | nd | nd |
| 5 | PHE | 1 (3.0%) | 0.61 | 2.01 | 6.76 | - | 6.76 |
| 6 | ANT | 3(9.1%) | 0.56 | 1.85 | 10.89 | 10.73 | 11.12 |
| 7 | FLA | 0 | 0.14 | 0.46 | 0 | nd | nd |
| 8 | PYR | 0 | 0.87 | 2.88 | 0 | nd | nd |
| 9 | B(c)F | 0 | 0.18 | 0.60 | 0 | nd | nd |
| 10 | CP(c,d)P | 0 | 0.82 | 2.71 | 0 | nd | nd |
| 11 | B(a)A | 0 | 0.24 | 0.80 | 0 | nd | nd |
| 12 | CHR | 0 | 0.20 | 0.67 | 0 | nd | nd |
| 13 | 5-M-CHR | 0 | 0.24 | 0.80 | 0 | nd | nd |
| 14 | B(b)F | 0 | 0.35 | 1.15 | 0 | nd | nd |
| 15 | B(k)F | 0 | 0.39 | 1.28 | 0 | nd | nd |
| 16 | B(a)P | 0 | 0.79 | 2.59 | 0 | nd | nd |
| 17 | PER | 0 | 0.39 | 1.29 | 0 | nd | nd |
| 18 | I(1,2,3-cd)P | 0 | 0.56 | 1.85 | 0 | nd | nd |
| 19 | DB(a,h)A | 0 | 0.36 | 1.19 | 0 | nd | nd |
| 20 | B(g,h,i)PER | 0 | 0.58 | 1.90 | 0 | nd | nd |
| 21 | DB(a,l)P | 0 | 0.59 | 1.96 | 0 | nd | nd |
| 22 | DB(a,e)P | 0 | 0.30 | 1.52 | 0 | nd | nd |
| 23 | DB(a,i)P | 0 | 0.84 | 2.76 | 0 | nd | nd |
| 24 | DB(a,h)P | 0 | 0.57 | 1.88 | 0 | nd | nd |
| ∑24 PAHs | 11 (33.3%) | - | - | 33.11 | 5.09 | 241.15 |
Chromatogram of some PAH standards; (A) TPP as the internal standard, NPH (1); FLR (2); PHE (3); ANT (4); FLA (5); B[c]F (6); 5-M-CHR (7); B[b]F (8); B[g,h,i]PER (9); DB[a,e]P (10). (B) Detected PAHs in aftoon bread samples